Infectious Disease Therapeutics Market Size, Share & Trends Analysis By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV), By End-use (Hospital, Clinics), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Disease Type
                        1.1.2. End use
                        1.1.3. Regional scope
                        1.1.4. Estimates and forecast timeline
                    1.2. Research Methodology
                    1.3. Information Procurement
                        1.3.1. Purchased database
                        1.3.2. GVR’s internal database
                        1.3.3. Secondary sources
                        1.3.4. Primary research
                        1.3.5. Details of primary research
                    1.4. Information or Data Analysis
                    1.5. Market Formulation & Validation
                    1.6. Model Details
                    1.7. List of Secondary Sources
                    1.8. List of Primary Sources
                    1.9. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Disease Type outlook
                        2.2.2. End use outlook
                        2.2.3. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Infectious Disease Therapeutics Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Penetration & Growth Prospect Mapping
                    3.3. Market Dynamics
                        3.3.1. Market driver analysis
                        3.3.2. Market restraint analysis
                    3.4. Infectious Disease Therapeutics Market Analysis Tools
                        3.4.1. Industry Analysis - Porter’s
                            3.4.1.1. Supplier power
                            3.4.1.2. Buyer power
                            3.4.1.3. Substitution threat
                            3.4.1.4. Threat of new entrant
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Technological landscape
                            3.4.2.3. Economic landscape
Chapter 4. Infectious Disease Therapeutics: Disease Type Estimates & Trend Analysis
                    4.1. Infectious Disease Therapeutics Market: Key Takeaways
                    4.2. Infectious Disease Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
                    4.3. HIV
                        4.3.1. HIV market estimates and forecasts, 2018 to 2030, (USD Billion)
                    4.4. Hepatitis
                        4.4.1. Hepatitis market estimates and forecasts, 2018 to 2030, (USD Billion)
                    4.5. Influenza
                        4.5.1. Influenza market estimates and forecasts, 2018 to 2030, (USD Billion)
                    4.6. TB
                        4.6.1. TB market estimates and forecasts, 2018 to 2030, (USD Billion)
                    4.7. Malaria
                        4.7.1. Malaria market estimates and forecasts, 2018 to 2030, (USD Billion)
                    4.8. HPV
                        4.8.1. HPV market estimates and forecasts, 2018 to 2030, (USD Billion)
Chapter 5. Infectious Disease Therapeutics: End Use Estimates & Trend Analysis
                    5.1. Infectious Disease Therapeutics Market: Key Takeaways
                    5.2. Infectious Disease Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
                    5.3. Hospitals
                        5.3.1. Hospitals market estimates and forecasts, 2018 to 2030, (USD Billion)
                    5.4. Clinics
                        5.4.1. Clinic market estimates and forecasts, 2018 to 2030, (USD Billion)
                    5.5. Others
                        5.5.1. Other market estimates and forecasts, 2018 to 2030, (USD Billion)
Chapter 6. Infectious Disease Therapeutics Market: Regional Estimates & Trend Analysis
                    6.1. Regional Outlook
                    6.2. Infectious Disease Therapeutics Market by Region: Key Takeaways
                    6.3. North America
                        6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                                6.3.2. U.S.
                            6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.3.3. Canada
                            6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                    6.4. Europe
                        6.4.1. UK
                            6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.4.2. Germany
                            6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.4.3. France
                            6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.4.4. Italy
                            6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.4.5. Spain
                            6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.4.6. Denmark
                            6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.4.7. Sweden
                            6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.4.8. Norway
                            6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                    6.5. Asia Pacific
                        6.5.1. Japan
                            6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.5.2. China
                            6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.5.3. India
                            6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.5.4. Australia
                            6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.5.5. Thailand
                            6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.5.6. South Korea
                            6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                    6.6. Latin America
                        6.6.1. Brazil
                            6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.6.2. Mexico
                            6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.6.3. Argentina
                            6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                    6.7. MEA
                        6.7.1. South Africa
                            6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.7.2. Saudi Arabia
                            6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.7.3. UAE
                            6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
                        6.7.4. Kuwait
                            6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                        7.2.1. Novartis AG
                            7.2.1.1. Company overview
                            7.2.1.2. Financial performance
                            7.2.1.3. Product benchmarking
                            7.2.1.4. Strategic initiatives
                        7.2.2. Gilead
                            7.2.2.1. Company overview
                            7.2.2.2. Financial performance
                            7.2.2.3. Product benchmarking
                            7.2.2.4. Strategic initiatives
                        7.2.3. GlaxoSmithKline plc
                            7.2.3.1. Company overview
                            7.2.3.2. Financial performance
                            7.2.3.3. Product benchmarking
                            7.2.3.4. Strategic initiatives
                        7.2.4. Janssen Pharmaceutical, Inc.
                            7.2.4.1. Company overview
                            7.2.4.2. Financial performance
                            7.2.4.3. Product benchmarking
                            7.2.4.4. Strategic initiatives
                        7.2.5. F. Hoffmann-La Roche Ltd.
                            7.2.5.1. Company overview
                            7.2.5.2. Financial performance
                            7.2.5.3. Product benchmarking
                            7.2.5.4. Strategic initiatives
                        7.2.6. BioCryst Pharmaceuticals, Inc.
                            7.2.6.1. Company overview
                            7.2.6.2. Financial performance
                            7.2.6.3. Product benchmarking
                            7.2.6.4. Strategic initiatives
                        7.2.7. Merck & Co., Inc.
                            7.2.7.1. Company overview
                            7.2.7.2. Financial performance
                            7.2.7.3. Product benchmarking
                            7.2.7.4. Strategic initiatives
                        7.2.8. Boehringer Ingelheim GmbH
                            7.2.8.1. Company overview
                            7.2.8.2. Financial performance
                            7.2.8.3. Product benchmarking
                            7.2.8.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 3 North America infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 4 North America infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 5 U.S. infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 6 U.S. infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 7 Canada infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 8 Canada infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 9 Europe infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 10 Europe infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 11 Europe infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 12 Germany infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 13 Germany infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 14 UK infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 15 UK infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 16 France infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 17 France infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 18 Italy infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 19 Italy infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 20 Spain infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 21 Spain infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 22 Denmark infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 23 Denmark infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 24 Sweden infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 25 Sweden infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 26 Norway infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 27 Norway infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 28 Asia Pacific infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 29 Asia Pacific infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 30 Asia Pacific infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 31 Japan infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 32 Japan infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 33 China infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 34 China infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 35 India infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 36 India infectious disease therapeutics market, by end use, 2018 – 2030 (USD Billion)
Table 37 Australia infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 38 Australia infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 39 Thailand infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 40 Thailand infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 41 South Korea infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 42 South Korea infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 43 Latin America infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 44 Latin America infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 45 Latin America infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 46 Brazil infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 47 Brazil infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 48 Mexico infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 49 Mexico infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 50 Argentina infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 51 Argentina infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 52 Middle East and Africa infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 53 Middle East and Africa infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 54 Middle East and Africa infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
Table 55 South Africa infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 56 South Africa infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 57 Saudi Arabia infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 58 Saudi Arabia infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 59 UAE infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 60 UAE infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
Table 61 Kuwait infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
Table 62 Kuwait infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Infectious disease therapeutics: Market outlook
Fig. 8 Infectious disease therapeutics: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Industry value chain analysis
Fig. 13 Infectious disease therapeutics market driver impact
Fig. 14 Infectious disease therapeutics market restraint impact
Fig. 15 Infectious disease therapeutics market strategic initiatives analysis
Fig. 16 Infectious disease therapeutics market: Disease type movement analysis
Fig. 17 Infectious disease therapeutics market: Disease type outlook and key takeaways
Fig. 18 HIV market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 19 Hepatitis market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 20 Influenza market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 21 TB market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 22 Malaria market estimates and forecasts, 2018 - 2030
Fig. 23 HPV market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 24 Infectious disease therapeutics market: End Use movement analysis
Fig. 25 Infectious disease therapeutics market: End Use outlook and key takeaways
Fig. 26 Hospitals market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 27 Clinics market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 29 Global infectious disease therapeutics market: Regional movement analysis
Fig. 30 Global infectious disease therapeutics market: Regional outlook and key takeaways
Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 40 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 55 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)